BioCentury
ARTICLE | Clinical News

Prostate cancer vaccine: Phase I/II data

August 10, 2009 7:00 AM UTC

Medical Marketing International Group plc (LSE:MMG), Cambridge, U.K. Product: Prostate cancer vaccine Business: Cancer Molecular target: Prostate-specific membrane antigen ( PSMA) Description: DNA va...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article